| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/11/2006 | US20060099321 Cereal based food product comprising dha and/or epa |
| 05/11/2006 | US20060099276 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 05/11/2006 | US20060099143 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis |
| 05/11/2006 | CA2586212A1 Use of a corticosteroid in association with a diuretic and an antacid for the treatment of vascular stenosis and the prevention of vascular restenosis |
| 05/11/2006 | CA2585449A1 Novel [1,4]benzodiazepines as vasopressin v2 receptor antagonists |
| 05/11/2006 | CA2583694A1 Amorphous and polymorphic forms of telmisartan sodium |
| 05/11/2006 | CA2582048A1 Use of angiotensin-(1-7) for preventing and/or reducing the formation of neointima |
| 05/10/2006 | EP1655286A1 Process for producing low-melting crystal of free disopyramide base |
| 05/10/2006 | EP1655280A1 Dicarboxylic acid derivates with pharmaceutical properties |
| 05/10/2006 | EP1655055A1 Use of dapsone as a neuroprotector in cerebral infarction |
| 05/10/2006 | EP1655037A1 Serum cholesterol lowering agnet or preventive or therapeutic agent for atherosclerosis |
| 05/10/2006 | EP1655035A1 Treatment of heart failure with CSF-1 |
| 05/10/2006 | EP1655027A1 9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension and migraine |
| 05/10/2006 | EP1654362A2 5'-and 3'-capped aptamers and uses therefor |
| 05/10/2006 | EP1653981A1 Fish protein hydrolyzate |
| 05/10/2006 | EP1653979A1 Compositions containing macrophages and uses thereof |
| 05/10/2006 | EP1653978A1 Use of nitrite salts for the treatment of cardiovascular conditions |
| 05/10/2006 | EP1653965A1 Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases |
| 05/10/2006 | EP1653963A1 Nasal pharmaceutical composition of piribedil |
| 05/10/2006 | EP1653957A1 Piperidine compounds useful as malonyl-coa decarboxylase inhibitors |
| 05/10/2006 | EP1653953A2 Drug delivery methods and devices |
| 05/10/2006 | EP1653952A2 Oxazole compounds for the treatment of neurodegenerative disorders |
| 05/10/2006 | EP1653948A2 Use of 5-methoxytryptamine as a cardioprotective agent |
| 05/10/2006 | EP1653944A1 Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors |
| 05/10/2006 | EP1560812B1 Aminocyclohexyl ether compounds and uses thereof |
| 05/10/2006 | EP1478383A4 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 05/10/2006 | EP1450834B9 Allium sativum bulb absolutes and therapeutic or cosmetic uses |
| 05/10/2006 | EP1418911B1 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 05/10/2006 | EP1412354B1 DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A 2a? RECEPTOR AND THEIR USE AS MEDICAMENTS |
| 05/10/2006 | EP1379694B1 Methods and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna |
| 05/10/2006 | EP1370553B1 Rho-kinase inhibitors |
| 05/10/2006 | EP1294874B1 Cd154 variants and uses thereof |
| 05/10/2006 | EP1265838B9 Novel fatty acid analogous |
| 05/10/2006 | EP1255764B1 Purine derivatives |
| 05/10/2006 | EP1224205B1 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 05/10/2006 | EP1214091B1 Therapies for chronic renal failure using one or more integrin antagonists |
| 05/10/2006 | EP1137948B1 Methods and compositions to lower plasma cholesterol levels |
| 05/10/2006 | EP1104403B1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 05/10/2006 | EP1049700B9 Chemokine receptor antagonists and methods of use therefor |
| 05/10/2006 | EP1047423B1 Novel apoptosis inhibitors |
| 05/10/2006 | EP1016407B1 Xanthine derivatives for treating brain ischemia |
| 05/10/2006 | CN1771329A The use of PDE4D in the screening for medicaments against atherosclerosis |
| 05/10/2006 | CN1771245A Novel crystals of fluorobenzamide derivative |
| 05/10/2006 | CN1771239A Vitamin d3 lactone derivatives |
| 05/10/2006 | CN1769456A Recombinant a human peptide production method |
| 05/10/2006 | CN1769283A Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/10/2006 | CN1769282A Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/10/2006 | CN1769272A Tetrahydroisoquinoline derivative, its preparation method and pharmaceutical composition |
| 05/10/2006 | CN1768858A Composition and method for repairing nerve damage and enhancing functional recovery of nerve |
| 05/10/2006 | CN1768848A Chinese medicinal formulation for restoring cardiac muscle function and adjusting blood pressure and preparation method thereof |
| 05/10/2006 | CN1768831A Medicine for treating piles and its preparing process |
| 05/10/2006 | CN1768803A Medicine for treating hypertension and its preparing process |
| 05/10/2006 | CN1768795A Hawthorn fruit physiological activity |
| 05/10/2006 | CN1768783A Safflower and salvanobi acid formulation and preparation method thereof |
| 05/10/2006 | CN1768779A Soft capsule of'Yu Feng Ning Xin' and preparation thereof |
| 05/10/2006 | CN1768777A Compound formulation of astragalus root for treating cardiovascular and cerebrovascular diseases, its preparing process and application |
| 05/10/2006 | CN1768775A Prescription containing sweet clover component and its formulation |
| 05/10/2006 | CN1768774A Aucklandia root oil containing emulsion, its preparation process and use |
| 05/10/2006 | CN1768772A Compound formulation of breviscapine for treating cardiovascular and cerebrovascular diseases. its preparing process and application |
| 05/10/2006 | CN1768770A Quality control method of agavaceae extract medicinal formulation |
| 05/10/2006 | CN1768767A Spleen-benefiting mind-tranquilizing formulation and its production method |
| 05/10/2006 | CN1768763A Compound breviscapine pills |
| 05/10/2006 | CN1768762A Novel drug administering route of pantocrine injection, its preparation process and novel indications |
| 05/10/2006 | CN1768760A Medicinal composition containing safflower total flavone and its preparation process and usage |
| 05/10/2006 | CN1768756A Application of a kind of alpha glycosidase inhibitor in preparation of medicine to prevent or treat diabetic microvascular complication |
| 05/10/2006 | CN1768753A Medicinal composition containing bilobalide B and its preparation process and usage |
| 05/10/2006 | CN1768743A Telmisartan soft capsule and preparation method thereof |
| 05/10/2006 | CN1768740A Medicinal composition containing carthamin yellow and its preparation process and usage |
| 05/10/2006 | CN1768739A Application of soybean isoflavone as medicine for preventing cerebral ischemia |
| 05/10/2006 | CN1768735A Medicaments for diabetic complication and neuropathy, and uses thereof |
| 05/10/2006 | CN1768734A Sodium ferulate glucose infusion liquid and its preparation method |
| 05/10/2006 | CN1768591A Health-preserving preserved gastrodia tuber for middle aged and old aged people |
| 05/10/2006 | CN1768588A Cactus green tea(black tea) |
| 05/10/2006 | CN1255540C Vaccine-induced hepatitis B viral strain and uses thereof |
| 05/10/2006 | CN1255413C (Pyrido/thieno)-[f]-oxazepin-5-one derivatives as AMPA receptor positive regulator |
| 05/10/2006 | CN1255411C Benzoxathiepino [3,4-b] pyridine derivatives, process for their preparation and their use as medicaments |
| 05/10/2006 | CN1255406C Substituted 2-acyl-3-(heteroaryl)-imidazo [1,2-a] pyrimidines, and related pharmaceutical compoistions and methods |
| 05/10/2006 | CN1255403C Beta-carboline derivatives useful as inhibitors of phosphodiesterase |
| 05/10/2006 | CN1255401C Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 05/10/2006 | CN1255392C Colchinol derivatives as angiogenesis inhibitors |
| 05/10/2006 | CN1255391C COLCHINOL derivatives as vascular damaging agents |
| 05/10/2006 | CN1255386C Substituted fused heterocyclic compounds |
| 05/10/2006 | CN1255151C Compound Longxue scorpion and preparation method thereof |
| 05/10/2006 | CN1255134C Externally applied medicinal ointment for treating burns, scalds and piles |
| 05/10/2006 | CN1255122C Freeze dried powder injection of rhodiola root and its preparation process |
| 05/10/2006 | CN1255121C Method for preparing Gadol pharmaceutical preparation |
| 05/10/2006 | CN1255110C Chinese medicinal composition for treating coronary heart disease and its usage |
| 05/10/2006 | CN1255108C Preparation process of Xuesaitong guttate pills |
| 05/10/2006 | CN1255103C Diaryl cycloalkyl derivatives, the use thereof as PPAR activators and pharmaceutical compositions containing thereof |
| 05/10/2006 | CN1255098C Ophiopogonin enteric coated microsphere preparation and preparing process thereof |
| 05/10/2006 | CN1255049C Functional agent for decomposing nicotine and method of preparing the same |
| 05/09/2006 | US7041829 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 05/09/2006 | US7041796 C3b/C4b Complement Receptor-like molecules and uses thereof |
| 05/09/2006 | US7041794 Nucleotide sequence comprises at least one new SNP (single nucleotide polymorphism) |
| 05/09/2006 | US7041703 Particularly septic shock and/or autoimmune pathologies in which the aetiopathogenic role of inflammatory cytokines has been ascertained |
| 05/09/2006 | US7041700 Substituted benzopyran derivatives against arrhythmia |
| 05/09/2006 | US7041692 Methods of treating factor VIIa-associated conditions with compounds having an amine nucleus |
| 05/09/2006 | US7041687 Indazole compounds useful as protein kinase inhibitors |
| 05/09/2006 | US7041682 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 05/09/2006 | US7041676 Compounds, compositions, and methods |